Skip to content

Mithra Pharmaceuticals

Bankruptcy closed
Public limited companyfounded 1999Rue Saint-Georges 5, 4000 Liège, BelgiumKBO/BCE: BE 0466.526.646
Summary

Mithra Pharmaceuticals was declared bankrupt on 10-06-2024 (Tribunal de l’entreprise de Liège, division Liège); according to the publications in the Belgian Official Gazette the procedure is no longer open (latest notice 27-08-2026). The 2022 annual accounts show equity of €290.2m and a net result of -€42.5m.

Mithra PharmaceuticalsBankruptcy closed

Are you a creditor?

Open bankruptcy Source: KBO register

The KBO register records a bankruptcy for this company. If it owes you money, you are not paid automatically: you file your claim yourself.

The procedure

The publication of the judgment is not in our data. Court, date and trustee are in RegSol: search by the enterprise number.

What to do now

  1. Stop delivering on credit unless the trustee agrees.
  2. Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
  3. File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
  4. Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
  5. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered, subject to conditions.
  6. Follow the file in RegSol: the verification report (admitted or disputed) and the trustee's reports appear there.

Deadlines: the judgment sets the last day to file your claim, by law at most thirty days after the judgment, and the day of the first verification report. Both dates are in the publication in the Official Gazette and in RegSol; Checked does not read them yet. A late claim is sometimes still possible, but not without consequences.

File a claim in RegSol ↗ Follow Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the trustee, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Embed the Mithra Pharmaceuticals company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21201
2 sites
Size
€23.3mturnover 2022
Staff
40 FTE
Equity
€290.2m
Loss
-€42.5m
Standalone figures, without subsidiaries
Financial health
Bankruptcy closed: no score
Structure
Holdings
6
0 of 115 deeds read
Signalsraises riskBankruptcy closedneutralLatest accounts filed on timeShow the evidence

Signals

Two signals.
raises riskneutral
raises risk · Bankruptcy closed
The Belgian Official Gazette published the closure of the bankruptcy. The latest notice is dated 27-08-2026. The KBO register has not yet processed that closure. The register usually follows the Belgian Official Gazette later, so the newer publication in the Gazette prevails.
Belgian Official Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 12-06-2023, 49 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2022
49 days early
2021
37 days early
2020
46 days early
2019
31 days early
2018
40 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 41 days before the deadline; the sector median (NACE 21) for financial year 2022 is 13 days before the deadline, and 34% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Supervising judge replacedEnterprise Court of Liège, Liège…
  2. Date of cessation of payments moved…Enterprise Court of Liège, Liège…
  3. Judicial dissolution and immediate closureEnterprise Court of Antwerp, Hasselt…

Key points

  • Risk: Declared bankrupttrustee not known Bankruptcy View
  • Caution: Result fell in 2022from -€883,845 to -€42.5m ▼ 4,713% View
  • Heads a groupcompanies controlled 6 View

By topic

Financials

Financial year
2022
Turnover
€23.3m
Loss
-€42.5m
Solvency
56.5%
Turnover▲ 48.5%
Net result
20182022
Go to Financials

Timeline

Events
42
Since
2001
  1. 14-06-2024Opening
  2. 13-06-2023Annual accounts filed
  3. 12-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201
Founded
13-07-1999
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Investigating this company? Keep it with today's facts in a case file.